| 2021 |
PKP3 protein levels are stabilized in response to canonical Wnt ligand or dominant-active LRP6 receptor, similar to beta-catenin and p120-catenin-isoform1; PKP3 associates with GSK3β and Axin (destruction complex components), and its levels are reduced upon overexpression of GSK3β or Axin; PKP3 trans-localizes into the nucleus in response to Wnt-ligand and its exogenous expression stimulates a Wnt reporter. |
Co-immunoprecipitation (PKP3 with GSK3β and Axin), luciferase Wnt reporter assay, nuclear localization imaging, overexpression and dominant-active receptor constructs |
Biochemical and biophysical research communications |
Medium |
34058472
|
| 2018 |
PKP3 activates the mTOR pathway via interaction with upstream MAPK pathway components to regulate autophagy and invasion in ovarian cancer; silencing PKP3 decreased proliferation, colony formation, and invasion, while overexpression upregulated these activities. |
siRNA knockdown, overexpression, pathway inhibitor assays, cell proliferation/invasion assays |
Biochemical and biophysical research communications |
Low |
30527804
|
| 2018 |
miR-149 directly decreases PKP3 expression; the carcinogen DNP upregulates miR-149 to suppress PKP3, thereby promoting NPC cell proliferation, adhesion, migration, and invasion; inhibition of miR-149 rescued PKP3 levels and blocked these pro-metastatic effects. |
miR-149 inhibitor rescue experiments, western blot, migration/invasion assays in NPC cell lines |
Molecular carcinogenesis |
Low |
30144176
|
| 2024 |
FERMT1 upregulates PKP3 expression and activates the p38 MAPK signaling pathway; knockdown of PKP3 counteracts the p38 MAPK activation induced by FERMT1 overexpression, placing PKP3 downstream of FERMT1 and upstream of p38 MAPK in a migration/invasion-promoting axis in NSCLC. |
siRNA knockdown of PKP3, FERMT1 overexpression, western blot for p38 MAPK pathway components, Transwell migration/invasion assays |
BMC cancer |
Low |
38200443
|
| 2025 |
miR-10b-5p directly targets the PKP3 3'UTR (validated by dual luciferase reporter assay) to suppress PKP3 expression; reduced PKP3 inhibits the RIPK3/MLKL necroptosis signaling pathway, promoting LUAD cell proliferation and suppressing necroptosis; PKP3 knockdown phenocopies miR-10b-5p overexpression and suppresses RIPK3/MLKL activation. |
Dual luciferase reporter assay, western blot (RIPK3/MLKL), siRNA knockdown of PKP3, miR-10b-5p overexpression/inhibition, xenograft mouse model |
Oncology reports |
Medium |
40116080
|
| 2025 |
circFOXK2 acts as a sponge for miR-328-5p to upregulate PKP3, thereby promoting NSCLC cell proliferation, migration, and invasion; direct binding between miR-328-5p and circFOXK2 was validated by dual luciferase reporter assay. |
Dual luciferase reporter assay, qRT-PCR, CCK-8 proliferation assay, wound healing and Transwell invasion assays |
Cellular and molecular biology |
Low |
41351372
|
| 2021 |
A sequence in the gene body of PKP3 exhibits methylation-dependent promoter activity in lung epithelial cells, demonstrated by luciferase reporter assays comparing methylated vs. unmethylated constructs; this region is hypermethylated in blood from cystic fibrosis patients with severe phenotype. |
Luciferase reporter assay with methylated and unmethylated PKP3 gene-body sequence in lung epithelial cells, bisulfite next-generation sequencing |
Epigenetics |
Medium |
34415821
|
| 2023 |
PKP3 augments ERCC1 expression by activating the MAPK pathway; CFDTW treatment reduces PKP3 expression by enhancing methylation of the PKP3 promoter, which promotes proliferation and reduces apoptosis in ovarian granulosa cells through the PKP3/MAPK/ERCC1 axis. |
PKP3 overexpression/knockdown, ERCC1 expression analysis, MAPK pathway western blot, promoter methylation analysis, cell proliferation/apoptosis assays |
Journal of ovarian research |
Low |
37420272
|